Pazdur’s exit at FDA has biotech afraid of agency ‘tipping point’news2025-12-02T16:33:34+00:00December 2nd, 2025|Endpoints News|
House passes bill to reauthorize rare pediatric PRV program; Senate nextnews2025-12-02T03:29:54+00:00December 2nd, 2025|Endpoints News|
New ACIP chair claims Covid-19 vaccines caused cancer, miscarriagesnews2025-12-01T21:23:50+00:00December 1st, 2025|Endpoints News|
FDA and Prasad’s Covid vaccine death claims lack key detailsnews2025-12-01T20:24:17+00:00December 1st, 2025|Endpoints News|
Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS saysnews2025-11-26T19:14:48+00:00November 26th, 2025|Endpoints News|
Novo submits high-dose Wegovy for FDA approval using vouchernews2025-11-26T17:45:45+00:00November 26th, 2025|Endpoints News|
Delayed panel on vaccine injury payments to meet next monthnews2025-11-26T16:44:30+00:00November 26th, 2025|Endpoints News|
FDA pushes back Ascendis’ dwarfism drug decision date by three monthsnews2025-11-26T13:57:06+00:00November 26th, 2025|Endpoints News|
Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgANnews2025-11-26T00:52:17+00:00November 26th, 2025|Endpoints News|
FDA approves Novartis’ Itvisma for older patients with spinal muscular atrophynews2025-11-25T12:09:26+00:00November 25th, 2025|Endpoints News|
